American Anti-corruption Law Envelops The Globe, Hits Graft Even In China
This article was originally published in PharmAsia News
Executive Summary
BEIJING - The U.S. is stepping up enforcement of its Foreign Corrupt Practices Act to combat bribery of government officials across great swaths of the globe, and even the health care sector as far away as Asia has not been immune in this anti-graft campaign
You may also be interested in...
China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm
BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities
China Sky One's Leaders Aim To Derail Potential Shareholders' Suit Headed By California Law Firm
BEIJING - Just weeks after alleging that U.S. media reports constituted "reckless criticism and attacks" for suggesting that China Sky One Medical misreported earnings, the Chinese firm has now confirmed that it filed inaccurate revenue statements with Chinese commercial authorities
China Sky One Blames U.S. Media Reports For Driving Down NASDAQ Share Price
BEIJING - Just months after threatening to sue an American shareholder for posting negative reports about China Sky One Medical on a U.S. Web site, the leadership of NASDAQ-traded Sky One has issued a new public declaration that unfavorable media reports about the firm that have been driving down its share price are unfounded and reckless